Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.76%
#4 aPriori aPriori +108.27%
#5 Bedrock Bedrock +74.39%
#6 Cysic Cysic +49.09%
#7 Prom Prom +38.71%
#8 Playnance Playnance +35.10%
#9 COTI COTI +26.15%
#10 Nillion Nillion +24.13%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Kiaro Holdings Corp. Kiaro Holdings Corp.

Kiaro Holdings Corp.

KIARF
Rank in Stocks #42670
Kiaro Holdings Corp. is a Canadian enterprise primarily engaged in the retail... Kiaro Holdings Corp. is a Canadian enterprise primarily engaged in the retail and wholesale distribution of cannabis products. The company operates through three distinct divisions: its network of retail cannabis stores, a wholesale cannabis business, and an e-commerce platform. Kiaro offers a range of cannabis and related merchandise. Beyond its physical retail presence, the firm also manages an online portal selling consumption accessories to customers in Canada, the United States, and Australia. Furthermore, it supplies cannabis goods via wholesale channels to other licensed retailers in Saskatchewan. Kiaro's products are available through its seventeen physical outlets located across British Columbia, Saskatchewan, and Ontario, as well as its digital storefront. The company's main office is situated in Vancouver, Canada.
Share Price
$0.00001
Last synced: 2026-03-26
Market Cap
$442.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Kiaro Holdings Corp. (KIARF)

Category

Healthcare
Revenue for Kiaro Holdings Corp. (KIARF)
Revenue in Aug 2026 TTM: 0
According to Kiaro Holdings Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kiaro Holdings Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US